Eiman Ibrahim
Impact in
-
- Cancer Treatment and Pharmacology
-
- Parathyroid Disorders and Treatments
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 2
-
- Cancer-related cognitive impairment studies 2
- Ferroptosis and cancer prognosis 2
- Co-authors
- Barbara E. Ehrlich (4 shared papers)Naifa L. Busaidy (2 shared papers)Mohamed Elfil (1 shared paper)Kate Nyhan (1 shared paper)Brenda Cartmel (1 shared paper)Sarah S. Mougalian (1 shared paper)Callisia N. Clarke (1 shared paper)Steven G. Waguespack (1 shared paper)
- Journals
- Cancer Research (1 paper)Frontiers in Pediatrics (1 paper)Breast Cancer Research (1 paper)Frontiers in Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesPolandSudan
In The Last Decade
Eiman Ibrahim
15 papers receiving 266 citations
Peers
Comparison fields: 5 of 59
- Oncology 172
- Nephrology 36
- Dermatology 39
- Genetics 36
- Biological Psychiatry 6
Countries citing papers authored by Eiman Ibrahim
This map shows the geographic impact of Eiman Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiman Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiman Ibrahim more than expected).
Fields of papers citing papers by Eiman Ibrahim
This network shows the impact of papers produced by Eiman Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiman Ibrahim. The network helps show where Eiman Ibrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Eiman Ibrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 118 | |
| 2 | 2019 | 38 | |
| 3 | 2021 | 34 | |
| 4 | 2017 | 28 | |
| 5 | 2018 | 11 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2023 | 0 |
About Eiman Ibrahim
Eiman Ibrahim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Surgery and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 270 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer-related cognitive impairment studies (2 papers), Ferroptosis and cancer prognosis (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Pancreatic function and diabetes (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (172 citations), Nephrology (36 citations), Dermatology (39 citations), Genetics (36 citations) and Biological Psychiatry (6 citations). Eiman Ibrahim has collaborated with scholars based in United States, Poland and Sudan. Frequent co-authors include Barbara E. Ehrlich, Naifa L. Busaidy, Mohamed Elfil, Kate Nyhan, Brenda Cartmel, Sarah S. Mougalian, Callisia N. Clarke, Steven G. Waguespack, Ramona Dadu and Michelle D. Williams. Their work appears in journals such as Cancer Research, Frontiers in Pediatrics, Breast Cancer Research, Frontiers in Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.